ResMed Announces Participation in Morgan Stanley’s 22nd Annual Global Healthcare Conference

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, Chairman and CEO, and Dr. Carlos Nunez, Chief Medical Officer, will participate in an informal meeting during Morgan Stanley’s 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, beginning at approximately 10:00 a.m. (Eastern Daylight Time) at the New York Marriott Marquis in New York, NY.

Further information about this event, including access to the live, audio-only webcast, is available at https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours following the conclusion of the live webcast and will be accessible for the following thirty (30) days.